Cumberland Pharmaceuticals (CPIX) Tops Q2 EPS by 15c

Cumberland Pharmaceuticals (NASDAQ: CPIX) reported Q2 EPS of $0.08, $0.15 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $9.1 million versus the consensus estimate of $8.57 million.

For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Waste stocks ride AI and healthcare boom as CLH surges 27%
• Freedom Broker Starts Unity Bancorp (UNTY) at Hold